| Dr Yeneisha Greene, MD | |
|
4201 Wilson Boulevard, Arlington, VA 22230 | |
| (703) 292-4401 | |
| Not Available |
| Full Name | Dr Yeneisha Greene |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 4201 Wilson Boulevard, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841459922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | D007129 (Maryland) | Primary |
| 207QA0505X | Family Medicine - Adult Medicine | MD039829 (District Of Columbia) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
A new study conducted by researchers from Boston University has found that sarcoidosis accounts for 25 percent of all deaths among women in the Black Women's Health Study who have the disease. The study is the largest epidemiologic study to date to specifically address mortality in black females with sarcoidosis.
Today, at the occasion of the 4th DNDi Partners' Meeting in Rio de Janeiro, Brazil, Dr Carlos Gadelha, Secretary of Science, Technology and Strategic Products, Brazilian Ministry of Health, announced that Brazil's National Health Surveillance Agency (ANVISA) granted registration of a new paediatric dosage form of benznidazole, developed through a partnership between the Pernambuco State Pharmaceutical Laboratory (LAFEPE) of Brazil and the Drugs for Neglected Diseases initiative (DNDi).
HealthInsight, provider of the leading health incentive platform, today announced a new addition to its value-based wellness programs for patients with metabolic syndrome. The program is designed to detect and manage the syndrome's symptoms before the condition becomes chronic, thereby allowing individuals to take preventive action and manage their overall health while reducing on-going treatment costs.
Attending frequently with medically unexplained symptoms is distressing for both patient and doctor and effective treatment or management options are limited: one in five patients have symptoms that remain unexplained by conventional medicine.
Sirnaomics, Inc. announced today that the company has received two SBIR (Small Business Innovation Research) grants from National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID), of National Institute of Health (NIH). Sirnaomics, Inc., a biopharmaceutical company founded in early 2007, is dedicated to developing RNA interference (RNAi) therapeutics for treatment of critical human diseases.
› Verified 5 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043378656 PECOS PAC ID: 3779495858 Enrollment ID: O20080519000558 |
News Archive
A new study conducted by researchers from Boston University has found that sarcoidosis accounts for 25 percent of all deaths among women in the Black Women's Health Study who have the disease. The study is the largest epidemiologic study to date to specifically address mortality in black females with sarcoidosis.
Today, at the occasion of the 4th DNDi Partners' Meeting in Rio de Janeiro, Brazil, Dr Carlos Gadelha, Secretary of Science, Technology and Strategic Products, Brazilian Ministry of Health, announced that Brazil's National Health Surveillance Agency (ANVISA) granted registration of a new paediatric dosage form of benznidazole, developed through a partnership between the Pernambuco State Pharmaceutical Laboratory (LAFEPE) of Brazil and the Drugs for Neglected Diseases initiative (DNDi).
HealthInsight, provider of the leading health incentive platform, today announced a new addition to its value-based wellness programs for patients with metabolic syndrome. The program is designed to detect and manage the syndrome's symptoms before the condition becomes chronic, thereby allowing individuals to take preventive action and manage their overall health while reducing on-going treatment costs.
Attending frequently with medically unexplained symptoms is distressing for both patient and doctor and effective treatment or management options are limited: one in five patients have symptoms that remain unexplained by conventional medicine.
Sirnaomics, Inc. announced today that the company has received two SBIR (Small Business Innovation Research) grants from National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID), of National Institute of Health (NIH). Sirnaomics, Inc., a biopharmaceutical company founded in early 2007, is dedicated to developing RNA interference (RNAi) therapeutics for treatment of critical human diseases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yeneisha Greene, MD 4201 Wilson Boulevard, Arlington, VA 22230 Ph: () - | Dr Yeneisha Greene, MD 4201 Wilson Boulevard, Arlington, VA 22230 Ph: (703) 292-4401 |
News Archive
A new study conducted by researchers from Boston University has found that sarcoidosis accounts for 25 percent of all deaths among women in the Black Women's Health Study who have the disease. The study is the largest epidemiologic study to date to specifically address mortality in black females with sarcoidosis.
Today, at the occasion of the 4th DNDi Partners' Meeting in Rio de Janeiro, Brazil, Dr Carlos Gadelha, Secretary of Science, Technology and Strategic Products, Brazilian Ministry of Health, announced that Brazil's National Health Surveillance Agency (ANVISA) granted registration of a new paediatric dosage form of benznidazole, developed through a partnership between the Pernambuco State Pharmaceutical Laboratory (LAFEPE) of Brazil and the Drugs for Neglected Diseases initiative (DNDi).
HealthInsight, provider of the leading health incentive platform, today announced a new addition to its value-based wellness programs for patients with metabolic syndrome. The program is designed to detect and manage the syndrome's symptoms before the condition becomes chronic, thereby allowing individuals to take preventive action and manage their overall health while reducing on-going treatment costs.
Attending frequently with medically unexplained symptoms is distressing for both patient and doctor and effective treatment or management options are limited: one in five patients have symptoms that remain unexplained by conventional medicine.
Sirnaomics, Inc. announced today that the company has received two SBIR (Small Business Innovation Research) grants from National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID), of National Institute of Health (NIH). Sirnaomics, Inc., a biopharmaceutical company founded in early 2007, is dedicated to developing RNA interference (RNAi) therapeutics for treatment of critical human diseases.
› Verified 5 days ago
Roza H Hassen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1005 N Glebe Rd Ste 160, Arlington, VA 22201 Phone: 571-492-3045 Fax: 571-492-3046 | |
Dr. Mary Cathleen Nishimura, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 888 N Quincy St Unit 2105, Arlington, VA 22203 Phone: 717-609-5897 | |
Zain Jalal Sultan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 S Glebe Rd Ste 110, Arlington, VA 22202 Phone: 571-665-6480 Fax: 571-665-6481 | |
Dr. Carl W Mccord, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 N Glebe Rd Ste 700, Arlington, VA 22203 Phone: 571-933-4662 Fax: 866-343-0947 | |
Lee Baldwin Martin Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 437 N Park Dr, Ste 1, Arlington, VA 22203 Phone: 703-527-1339 Fax: 703-527-9733 | |
Dr. Janet F Regier, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4201 Wilson Blvd, Health Unit Room 265 S, Arlington, VA 22230 Phone: 703-292-4401 Fax: 703-292-9001 | |
Dr. Jennifer T Neria, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr, Suite 434, Arlington, VA 22205 Phone: 703-522-1860 Fax: 703-522-7293 |